Next Generation News and Research

RSS

Hemerus Medical’s SOLX red blood cell additive receives world's first CE Marking

Hemerus Medical, LLC, a Minnesota-based company that develops innovative technologies for the collection, processing, preservation, and storage of blood products announced that it has received the world's first CE Marking for a 56 day red blood cell storage solution – the SOLX red blood cell additive (AS-7).

18 Sep 2012

Bruker introduces new solariX XR Fourier Transform Mass Spectrometer with ParaCell

At the 19th International Mass Spectrometry Conference, Bruker today introduced the breakthrough new solariX XR Fourier Transform Mass Spectrometer (FTMS) with the revolutionary ParaCell for extreme mass resolution greater than 10 million.

17 Sep 2012

New NHGRI grants to help develop technologies to dramatically reduce DNA sequencing costs

Grants of almost $19 million will help to develop technologies to dramatically reduce the cost of DNA sequencing, the National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, announced today.

15 Sep 2012

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

Tangent Medical, an innovator in IV therapy products, today announced it has received FDA 510(k) clearance for the NovaCath Secure IV Catheter System, a product designed to set new standards in peripheral IV catheter design, functionality and performance.

14 Sep 2012

UWM, GE Healthcare partner to develop advanced medical imaging software

Combining industrial leadership and academic prowess, GE Healthcare and the University of Wisconsin-Milwaukee (UWM) today announced a unique collaboration aimed at building a pipeline of Wisconsin-based medical imaging software developers and researchers to drive the next generation of healthcare technology globally.

13 Sep 2012

PrimeraDx’s ICEPlex system and C. difficile detection assay receive CE mark

PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex system, a quantitative multiplex PCR system, and their C. difficile detection assay both received the CE mark.

12 Sep 2012

Electronic jewelry for health

Bracelets and amulets are in the works at Dartmouth's Institute for Security, Technology, and Society (ISTS). Rather than items of mere adornment, the scientists and engineers are constructing personal mobile health (mHealth) devices-highly functional jewelry, as it were.

12 Sep 2012

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

GE Healthcare today announced pooled results from phase III brain autopsy and biopsy studies on the investigational PET amyloid imaging agent, [18F]flutemetamol, which showed a strong concordance between [18F]flutemetamol images and Alzheimer's disease-associated beta amyloid brain pathology.

11 Sep 2012

Albert Einstein College of Medicine to educate faculty members and students on social media

Social media is increasingly popular but engaging in its proper use can prove confusing and challenging - especially in the medical and healthcare arenas. Albert Einstein College of Medicine of Yeshiva University has been awarded a two-year grant to educate faculty members and medical students on using social media appropriately and effectively.

11 Sep 2012

First demonstration of newly developed dual humanized FRGTM KO system against malaria

A novel human liver-chimeric mouse model developed at Oregon Health & Science University and Yecuris Corporation has made possible a research breakthrough at Seattle Biomedical Research Institute that will greatly accelerate studies of the most lethal forms of human malaria.

11 Sep 2012

Annovation Biopharma to develop novel anesthetics with $8M Series A financing

Annovation Biopharma, a biotechnology company focused on creating more effective, safer therapies for anesthesia and critical care, has raised $8M in a Series A financing led by Atlas Venture, Partners Innovation Fund, and new strategic investor The Medicines Company.

10 Sep 2012

Florida Hospital Tampa adopts FDA approved Trevo Pro Clot Retriever

Florida Hospital Tampa and Dr. James E. Lefler are the first in the Tampa Bay area to adopt the new FDA approved device called the Trevo Pro Clot Retriever manufactured by Stryker. The Trevo Pro is the next generation in clot removal technology.

10 Sep 2012

AB SCIEX launches Eksigent ekspert nanoLC 400 system

AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the Eksigent ekspert nanoLC 400 system.

10 Sep 2012

Scientists characterize the lung squamous cell carcinoma genome

In the September 9, 2012 early online edition of Nature, scientists with The Cancer Genome Atlas (TCGA) report that they have characterized the lung squamous cell carcinoma genome.

10 Sep 2012

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Kalidex Pharmaceuticals, a privately-held anti-infective company, today announced the presentation of data on its lead development candidate KPI-10, a broad spectrum, next-generation fluoroquinolone, at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco, September 9 through 12.

7 Sep 2012

Ingenuity Systems, ShanghaiBio sign collaboration agreement

ShanghaiBio Corporation and Ingenuity Systems have signed a collaboration agreement enabling ShanghaiBio Corporation to extend its current lab service offering to include Ingenuity solutions for downstream analysis and interpretation of genomics data. ShanghaiBio Corporation will complement their sequencing, genotyping and gene expression lab services by creating a bundled solution with Ingenuity's applications, which combine analytics and biomedical content to help get actionable insights from experiments.

6 Sep 2012

New approach can help researchers study genetic variations associated with disease

With the ability to sequence human genes comes an onslaught of raw material about the genetic characteristics that distinguish us, and wading through these reserves of data poses a major challenge for life scientists. Researchers at Roswell Park Cancer Institute (RPCI) and the Center for Human Genome Variation at Duke University Medical Center (DUMC) have developed an approach for analyzing data that can help researchers studying genetic factors in disease to quickly cull out relevant genetic patterns and identify variants that lead to particular disorders.

6 Sep 2012

New cell screening method can identify potential anti-influenza drugs

Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs.

6 Sep 2012

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

ImmunoCellular Therapeutics, Ltd. announced today that the company has completed enrollment for its Phase II randomized, double-blinded, placebo-controlled, multi-center trial of its dendritic cell-based cancer vaccine ICT-107 for treatment of glioblastoma.

6 Sep 2012

DuraSite 2 ophthalmic drug delivery system from InSite Vision

InSite Vision Incorporated today introduced DuraSite 2, its next-generation enhanced drug delivery system which provides a broad platform for developing superior ophthalmic therapeutics.

6 Sep 2012

Next Generation News and Research

Hemerus Medical’s SOLX red blood cell additive receives world's first CE Marking

Bruker introduces new solariX XR Fourier Transform Mass Spectrometer with ParaCell

New NHGRI grants to help develop technologies to dramatically reduce DNA sequencing costs

FDA clears Tangent Medical’s NovaCath Secure IV Catheter System

UWM, GE Healthcare partner to develop advanced medical imaging software

PrimeraDx’s ICEPlex system and C. difficile detection assay receive CE mark

Electronic jewelry for health

GE Healthcare announces data from [18F]flutemetamol phase III studies on Alzheimer's

Albert Einstein College of Medicine to educate faculty members and students on social media

First demonstration of newly developed dual humanized FRGTM KO system against malaria

Annovation Biopharma to develop novel anesthetics with $8M Series A financing

Florida Hospital Tampa adopts FDA approved Trevo Pro Clot Retriever

AB SCIEX launches Eksigent ekspert nanoLC 400 system

Scientists characterize the lung squamous cell carcinoma genome

Kalidex announces presentation of data on KPI-10 against MDR strains at ICAAC

Ingenuity Systems, ShanghaiBio sign collaboration agreement

New approach can help researchers study genetic variations associated with disease

New cell screening method can identify potential anti-influenza drugs

ImmunoCellular completes enrollment in ICT-107 Phase II trial for glioblastoma

DuraSite 2 ophthalmic drug delivery system from InSite Vision

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News